Literature DB >> 12696370

[Sleeping sickness: one hundred years of control strategy evolution].

F J Louis1, P P Simarro, P Lucas.   

Abstract

Sleeping sickness has been known since the fifteenth century but the real progress in the knowledge of the disease occurred in the nineteenth century with the development of microscopy. From 1841 to 1901 the parasites and their vectors have been identified, the symptomatology and the epidemiology have been described. However, due to absence of any effective cure, the campaign against the disease was still based on the isolation of the patients and the transfer of exposed populations. The discovery of atoxyl in 1905 provided doctors with their first therapeutic weapon and, in 1910, the first action of vector control was undertaken with success in the Island of Principe. Between the two world conflicts, Jamot published the rules to fight against major outbreaks. Their application in Oubangui-Chari, in Cameroon and in French Occidental Africa brought tremendous results and signed the triumph of the mobile unit concept. Success which will not be denied until the sixties when the disease was believed to be eradicated. From the sixties to the nineties, the concept of the integration of prevention and care added to the exclusion of any vertical system will result in a progressive reniewed outbreak of the sleeping sickness in the known foci. As a paradox, it is a time rich in discovery as regards diagnosis, treatment and entomology. In 1994, the World Health Organisation got concerned with the situation of the disease in Central Africa where the outbreak of the disease reinforced. A second paradox appeared; it is the next to total disinterest from the politics and fund raisers which will save the disease. Today, sleeping sickness is the typical example of the orphan disease, a show case brandished by all the good souls. In 2001, an agreement between the WHO and the pharmaceutical industry brings back the financial funds required to fight the disease. Basically, it is a matter of resuming the action by using what is still existing and by creating new strategies considering the extreme lack of human and logistical resources. The objective is to eradicate the sleeping sickness as a public health problem. The challenge is huge, but is on the way to success.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12696370

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  6 in total

1.  Comparative Genomics of Glossina palpalis gambiensis and G. morsitans morsitans to Reveal Gene Orthologs Involved in Infection by Trypanosoma brucei gambiense.

Authors:  Illiassou Hamidou Soumana; Bernadette Tchicaya; Stéphanie Rialle; Hugues Parrinello; Anne Geiger
Journal:  Front Microbiol       Date:  2017-04-03       Impact factor: 5.640

2.  Prevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan.

Authors:  Francesco Checchi; Andrew P Cox; François Chappuis; Gerardo Priotto; Daniel Chandramohan; Daniel T Haydon
Journal:  Parasit Vectors       Date:  2012-08-07       Impact factor: 3.876

3.  Transcriptional Profiling of Midguts Prepared from Trypanosoma/T. congolense-Positive Glossina palpalis palpalis Collected from Two Distinct Cameroonian Foci: Coordinated Signatures of the Midguts' Remodeling As T. congolense-Supportive Niches.

Authors:  Jean M Tsagmo Ngoune; Flobert Njiokou; Béatrice Loriod; Ginette Kame-Ngasse; Nicolas Fernandez-Nunez; Claire Rioualen; Jacques van Helden; Anne Geiger
Journal:  Front Immunol       Date:  2017-07-28       Impact factor: 7.561

4.  The burden of human African trypanosomiasis.

Authors:  Eric M Fèvre; Beatrix V Wissmann; Susan C Welburn; Pascal Lutumba
Journal:  PLoS Negl Trop Dis       Date:  2008-12-23

5.  Trypanosoma brucei gambiense adaptation to different mammalian sera is associated with VSG expression site plasticity.

Authors:  Carlos Cordon-Obras; Jorge Cano; Dolores González-Pacanowska; Agustin Benito; Miguel Navarro; Jean-Mathieu Bart
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

Review 6.  Epidemiology of human African trypanosomiasis.

Authors:  Jose R Franco; Pere P Simarro; Abdoulaye Diarra; Jean G Jannin
Journal:  Clin Epidemiol       Date:  2014-08-06       Impact factor: 4.790

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.